News from the healthcare data industry
Series B Round to Accelerate PurpleLab’s Investment in Real-World Evidence Solutions Built on the Company’s HealthNexus™ Platform September 12, 2022 09:05 AM Eastern Daylight Time WAYNE, Pa.–(BUSINESS WIRE)–PurpleLab, Inc. today announced...
Lyon, France, September 9, 2022 – Centre Léon Bérard (CLB), a Comprehensive Cancer Center in Lyon and Rhône-Alpes has joined the TriNetX global health research network. The TriNetX Network is comprised...
September 09, 2022 10:50 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Verily today announced a $1 billion dollar investment round led by Alphabet, that will be used to support...
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced three abstracts were accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2022, which convenes...
SAN FRANCISCO, Sept. 8, 2022 /PRNewswire/ — Verana Health®—a digital health company elevating quality in real-world data—today announced it will present two research posters at the American College of Epidemiology (ACE) 2022 Annual Meeting,...
Minneapolis, MN – WEBWIRE – Wednesday, September 7, 2022 “Partnering with ENT Partners contributes to our mission to deliver the largest secure, privacy-compliant, real-world ENT dataset for researchers around the world,” Omer Dror,...
Datavant launches international expansion and acquires Convenet, a health technology infrastructure company in the UK that has built the world’s first NHS approved API powering integration into the NHS Spine...
Presentations to highlight role of liquid biopsy tests and real-world data to identify biomarkers, predict patient response to therapy, and detect resistance mechanisms in late-stage cancers September 06, 2022 08:05 AM...
We are excited to announce the launch of Datavant Trials, a new web-based trial tokenization solution that helps bridge the gap between clinical trial and real-world data (RWD) to accelerate...
– The company is pioneering a new approach for the development and improvement of its test platform by combining multiomics with real-world data – The Sanderson Study underscores Freenome’s commitment to...